Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A

PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

November 22, 2018

Study Completion Date

November 22, 2018

Conditions
Influenza A
Interventions
DRUG

Low dose of VIS410

Single intravenous infusion of fixed low dose of VIS410 in addition to oseltamivir

DRUG

High dose of VIS410

Single intravenous infusion of fixed high dose of VIS410 in addition to oseltamivir

DRUG

Placebo

Single intravenous infusion of placebo in addition to oseltamivir

Trial Locations (114)

1023

Visterra, Auckland

1070

Visterra, Brussels

1233

Visterra, Sofia

1431

Visterra, Sofia

1501

Visterra, Benoni

1606

Visterra, Sofia

2006

Visterra, Auckland Park

2025

Visterra, Auckland

2145

Visterra, Westmead

2650

Visterra, Edegem

3050

Visterra, Parkville

3168

Visterra, Melbourne

3320

Visterra, Kozloduy

3400

Visterra, Montana

4002

Visterra, Plovdiv

4092

Visterra, Durban

4101

Visterra, South Brisbane

4102

Visterra, Woolloongabba

5000

Visterra, Adelaide

Visterra, Veliko Tarnovo

6021

Visterra, Wellington

6850

Visterra, Worcester

7570

Visterra, Cape Town

10002

Visterra, Zhytomyr

10110

Visterra, Bangkok

10138

Visterra, Tallinn

10617

Visterra, Tallinn

11000

Visterra, Nonthaburi

12208

Visterra, Albany

13210

Visterra, Syracuse

14004

Visterra, Córdoba

17405

Visterra, York

18000

Visterra, Niš

18016

Visterra, Granada

18103

Visterra, Allentown

19141

Visterra, Philadelphia

21000

Visterra, Novi Sad

24014

Visterra, Roanoke

27403

Visterra, Greensboro

27710

Visterra, Durham

28007

Visterra, Madrid

28046

Visterra, Madrid

29000

Visterra, Quimper

30033

Visterra, Decatur

30342

Visterra, Atlanta

33713

Visterra, St. Petersburg

34000

Visterra, Taiping

Visterra, Kragujevac

34098

Visterra, Istanbul

36038

Visterra, Poltava

38700

Visterra, La Tronche

40002

Visterra, Khon Kaen

40021

Visterra, Sumy

43215

Visterra, Columbus

44000

Visterra, Nantes

44195

Visterra, Cleveland

48202

Visterra, Detroit

48903

Visterra, Barakaldo

50586

Visterra, Kuala Lumpur

51014

Visterra, Tartu

59701

Visterra, Butte

60637

Visterra, Chicago

61080

Visterra, Trabzon

65023

Visterra, Odesa

74370

Visterra, Metz-Tessy

75014

Visterra, Paris

75018

Visterra, Paris

76008

Visterra, Ivano-Frankivsk

80010

Visterra, Pärnu

83221

Visterra, Blackfoot

85000

Visterra, La Roche-sur-Yon

85724

Visterra, Tucson

87000

Visterra, Limoges

94305

Visterra, Stanford

98405

Visterra, Tacoma

99352

Visterra, Richland

113419

Visterra, Tallinn

119228

Visterra, Singapore

163045

Visterra, Arkhangelsk

210009

Visterra, Vitebsk

214006

Visterra, Smolensk

220024

Visterra, Minsk

223041

Visterra, Lesnoy

224027

Visterra, Brest

230017

Visterra, Grodno

230030

Visterra, Grodno

246029

Visterra, Homyel

246044

Visterra, Homyel

308433

Visterra, Singapore

420140

Visterra, Kazan'

600023

Visterra, Vladimir

630051

Visterra, Novosibirsk

634063

Visterra, Tomsk

E1C 6Z8

Visterra, Moncton

0144

Visterra, Tbilisi

0159

Visterra, Tbilisi

0160

Visterra, Tbilisi

LV5417

Visterra, Daugavpils

LV3414

Visterra, Liepāja

LV4600

Visterra, Rēzekne

LV 1002

Visterra, Riga

LV4201

Visterra, Valmiera

LV3601

Visterra, Ventspils

05350

Visterra, Alor Star

0157

Visterra, Lyttelton

0002

Visterra, Pretoria

0380

Visterra, Thabazimbi

03010

Visterra, Alicante

08916

Visterra, Badalona

08035

Visterra, Barcelona

08221

Visterra, Terrassa

06230

Visterra, Ankara

01133

Visterra, Kyiv

04112

Visterra, Kyiv

All Listed Sponsors
lead

Visterra, Inc.

INDUSTRY

NCT03040141 - Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A | Biotech Hunter | Biotech Hunter